特发性间质性肺炎伴自身抗体:随访1年的大样本病例系列
该回顾性单中心研究纳入124例明确分类的间质性肺病患者,比较伴自身抗体特发性间质性肺炎(AI-ILD)、间质性肺炎伴自身免疫特征(IPAF)、结缔组织病相关间质性肺病(CTD-ILD)及特发性肺纤维化(IPF)患者1年内肺功能变化。结果显示各组FVC变化无显著差异,DLCO变化有显著差异,但无临床显著区分意义。
要点
- AI-ILD、IPAF、CTD-ILD与Lone-IPF患者1年内FVC变化无显著差异。
- DLCO变化各组间有统计学差异,但未显示临床显著区分价值。
- UIP型患者FVC下降较NSIP型及不可分类型更明显。
核心结论
- 随访1年未观察到AI-ILD、IPAF、CTD-ILD与Lone-IPF之间肺功能有临床显著差异。
- 目前尚不清楚AI-ILD是独立表型还是IPAF的变异型,需更长随访。
研究设计与样本
- 回顾性单中心研究,纳入124例明确分类的间质性肺病患者。
- 分组:AI-ILD 20例,IPAF 15例,CTD-ILD 36例,Lone-IPF 53例。
主要发现
- AI-ILD组75%、IPAF组33%、CTD-ILD组33%为UIP型。
- 各组初始FVC和DLCO均呈相似中度下降。
- 12个月FVC平均变化:IPAF -60 mL,AI-ILD -110 mL,CTD-ILD -10 mL,Lone-IPF -90 mL(P = .52)。
- DLCO平均变化:IPAF 2.39 mL/mm Hg/min,AI-ILD -1.15 mL/mm Hg/min,CTD-ILD -0.27 mL/mm Hg/min,Lone-IPF -1.05 mL/mm Hg/min(P < .001)。
- 按疾病模式,FVC平均变化:UIP -140 mL,NSIP 10 mL,不可分类/其他 12 mL(P = .001)。
临床怎么用
- 对于伴自身抗体的特发性间质性肺炎患者,1年内肺功能随访不能可靠区分AI-ILD、IPAF、CTD-ILD与Lone-IPF。
- UIP型患者FVC下降更明显,应加强监测。
局限性
- 回顾性单中心设计。
- 随访时间仅1年。
- 样本量有限,各组例数不等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some patients with autoimmune characteristics and idiopathic interstitial pneumonia, particularly usual interstitial pneumonia (UIP), do not fit neatly into the category of connective tissue disease-associated interstitial lung disease (CTD-ILD), idiopathic pulmonary fibrosis (IPF), or recently proposed yet to be validated criteria for interstitial pneumonia with autoimmune features (IPAF). Outcomes of these patients are unknown. METHODS: This was a retrospective single-center study. Analyses of variance compared differences in mean change in FVC and diffusion capacity (Dlco) over 1 year among 124 well-defined patients (20 patients with positive autoantibodies with or without symptoms of connective tissue disease [AI-ILD], 15 patients with IPAF, 36 patients with CTD-ILD, and 53 patients with IPF with negative CTD serologies [Lone-IPF]). RESULTS: Of the patients, 75% with AI-ILD, 33% with IPAF, and 33% with CTD-ILD had UIP. Initial FVC and Dlco were similarly moderately reduced across groups. Mean change in FVC over 12 months was as follows: -60 mL (IPAF), -110 mL (AI-ILD), -10 mL (CTD-ILD), and -90 mL (Lone-IPF) (P = .52). Mean change in Dlco was as follows: 2.39 mL/mm Hg/min (IPAF), -1.15 mL/mm Hg/min (AI-ILD), -0.27 mL/mm Hg/min (CTD-ILD), and -1.05 mL/mm Hg/min (Lone-IPF) (P < .001). By pattern of disease, the mean change in FVC was as follows: -140 mL (UIP), 10 mL (nonspecific interstitial pneumonia), and 12 mL (unclassifiable/other) (P = .001). CONCLUSIONS: No clinically significant differences in pulmonary function to distinguish between patients with AI-ILD, IPAF, CTD-ILD, and Lone-IPF were observed after 1 year. Longer periods of follow-up are needed to understand the outcomes of these patients. It is not yet clear whether AI-ILD is a distinct phenotype or a variant of the newly proposed entity IPAF.
引用
- Collins BF, Spiekerman CF, Shaw MA, et al. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year. Chest. 2017. PMID: 28300570. doi:10.1016/j.chest.2017.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。